Verhagen E H, Hesselmann G M, Besse T C, de Graeff A
Integraal Kankercentrum Midden-Nederland, Postbus 19.079, 3501 DB Utrecht.
Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):458-61.
Palliative sedation is the intentional lowering of the level of consciousness ofa patient in the last phase of life by means of the administration of sedatives. The objective of palliative sedation is to relieve severe physical or psychological suffering that is otherwise untreatable. Sedation is used in 12% of all patients dying in the Netherlands. Refractory delirium, dyspnoea or pain are the most common indications. If deep palliative sedation is used, the estimated life expectancy should be a few days to at most one week. Midazolam is used most often for continuous sedation, usually by subcutaneous infusion; if the response is insufficient, a combination of midazolam with levomepromazine or phenobarbital or monotreatment with propofol may be used. If continuous infusion is not desired or feasible, intermittent administration of midazolam, diazepam, lorazepam or chlorpromazine may be considered. Provided that it is used under the right circumstances, palliative sedation does not shorten life.
姑息性镇静是指通过给予镇静剂,有意降低处于生命末期患者的意识水平。姑息性镇静的目的是缓解严重的身体或心理痛苦,而这些痛苦在其他情况下无法得到治疗。在荷兰,12% 的临终患者会使用镇静治疗。难治性谵妄、呼吸困难或疼痛是最常见的适应证。如果使用深度姑息性镇静,预计生存期应为几天至最多一周。咪达唑仑最常用于持续镇静,通常通过皮下输注;如果效果不佳,可使用咪达唑仑与左美丙嗪或苯巴比妥联合使用,或单独使用丙泊酚。如果不希望或不可行进行持续输注,可考虑间歇性给予咪达唑仑、地西泮、劳拉西泮或氯丙嗪。只要在正确的情况下使用,姑息性镇静不会缩短生命。